In addition, TP73-AS1 is upregulated in several types of human cancer, and TP73-AS1 knockdown effectively attenuates the progression of ovarian cancer [7], hepatocellular carcinoma [8], and bladder cancer [9]. Here, TP73 is linked to cancer.